https://www.google.com/search?q=cruxforce+llc+austin+texas&sca_esv=595096569&sxsrf=AM9HkKl_C5Z9r_KfUMjPGDnK8JVcP8yDYg%3A1704207925841&ei=NSaUZc3FMpGt1QGw4oSACA&oq=cruxforce+llc+austin+texa&gs_lp=EhNtb2JpbGUtZ3dzLXdpei1zZXJwIhljcnV4Zm9yY2UgbGxjIGF1c3RpbiB0ZXhhKgIIADIFECEYoAFI9kBQngxYijBwAHgAkAEAmAGxAaABtA6qAQQwLjEzuAEByAEA-AEBwgILEAAYgAQYogQYsAPCAgsQABiJBRiiBBiwA8ICBRAhGKsC4gMEGAEgQYgGAZAGBQ&sclient=mobile-gws-wiz-serp

Read December 5 offering.
The Company agreed to effectuate a reverse split in the event the closing bid price of the Class A ordinary share trades below $0.01 (closing price) for five consecutive trading days. The holders of the warrants agreed not to exercise cashlessly below $1.50 during the first 20 trading days after effectuation of the reverse split.

$HTBX awesome news TTIME!

$Good Morning AF!

$FET news link back
The Offer expired at 11:59 p.m., New York City time, on July 31, 2020. As of the expiration date, an aggregate principal amount of $315,489,000, or 96.14%, of the existing notes were validly tendered and not validly withdrawn. Accordingly, the minimum participation condition of 95% to the closing of the exchange offer has been satisfied.

$FET $CAPR $HTBX $IBIO $SNSS

$SNSS News The Offering is expected to close on July 31, 2020, subject to customary closing conditions. 

$HTBX still holding some of mine too, 1500. :)

$FET .50-.6944 today linkback

$Good late afternoon AF!

$FET Holy $FET! It has moved some today

$FET .54

$FET linkback .51s

$KODK still laughing, :) I'm definitely sharing that.

$SNSS Geez if they PR that we are in the money.

$KODK I LOVE IT! Thank you for sharing Makk1.

$SNSS wasnt even expecting it to be back at this level today. But I will take it :)

$SNSS .29s back

$SNSS PRICE OUT
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of its common stock. The public offering price of each share of common stock is $0.23.

Sunesis expects to receive gross proceeds of approximately $12 million from this offering, before deducting the underwriting discounts and estimated offering expenses. Sunesis has granted the underwriters a 30-day option to purchase up to an additional 7,826,086 shares of common stock to cover over-allotments, if any. This offering is expected to close on or about July 31, 2020, subject to customary closing conditions. Sunesis anticipates using the net proceeds from the proposed offering to fund ongoing development of PDK1 inhibitor SNS-510 and general corporate purposes.

$SNSS NEWS
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of its common stock. The public offering price of each share of common stock is $0.23.

Sunesis expects to receive gross proceeds of approximately $12 million from this offering, before deducting the underwriting discounts and estimated offering expenses. Sunesis has granted the underwriters a 30-day option to purchase up to an additional 7,826,086 shares of common stock to cover over-allotments, if any. This offering is expected to close on or about July 31, 2020, subject to customary closing conditions. Sunesis anticipates using the net proceeds from the proposed offering to fund ongoing development of PDK1 inhibitor SNS-510 and general corporate purposes.

$SNSS NEWS
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of its common stock. The public offering price of each share of common stock is $0.23.

Sunesis expects to receive gross proceeds of approximately $12 million from this offering, before deducting the underwriting discounts and estimated offering expenses. Sunesis has granted the underwriters a 30-day option to purchase up to an additional 7,826,086 shares of common stock to cover over-allotments, if any. This offering is expected to close on or about July 31, 2020, subject to customary closing conditions. Sunesis anticipates using the net proceeds from the proposed offering to fund ongoing development of PDK1 inhibitor SNS-510 and general corporate purposes.

$SNSS .25s up to bat

$SNSS .25s showing

$SNSS nice grab. Now lets see this move north again :)

$SNSS grabbed some at .2685 & .27

$HTBX hit $3+

$HTBX those are looking nice!

$SNSS down to .30s again

$SNSS .30s back

$HTBX Boom 2.90

$HTBX GM! Took off hard

$Good Morning AF!

$SNSS thanks for posting. Not sure but would imagine a pr should be coming. Would welcome it :)

$SNSS 8k
8k
On July 28, 2020, Sunesis Pharmaceuticals, Inc. (the “Company”) executed a payoff letter to repay in full all outstanding indebtedness and terminate all commitments and obligations under its term loan agreement dated April 26, 2019, as amended (“Loan Agreement”), with Silicon Valley Bank (“SVB”).  Under the payoff letter, the Company has agreed to pay to SVB approximately $5.7 million, which will satisfy all of the Company’s debt obligations, including a final payment equal to 4% of the original principal amount of the borrowing.   The material terms of the Loan Agreement are described in the Company’s Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on May 7, 2020.
The foregoing summary of the Loan Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to the Loan Agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 29, 2019, and is incorporated herein by reference.
 
Item 2.02. Results of Operations and Financial Condition.
On July 28, 2020, the Company filed a preliminary prospectus supplement with the SEC in which it disclosed that on a preliminary unaudited basis, the Company, estimates that its cash and cash equivalents as of June 30, 2020 to be approximately $17.7 million, which excludes restricted cash of $5.5 million. The estimate is preliminary estimate based on currently available information and does not present all necessary information for a complete understanding of the Company’s financial condition as of June 30, 2020 or the Company’s results of operations for the three and six months ended June 30, 2020.

$SNSS just noticed that.

$SNSS Got some at .2960-.2962 & .3025-.3051. If it dips again I'm grabbing more.

$SNSS added .29s &.30s

$$HTBX grabbed more at $2 to avg down

$Good Morning AF!

$CAPR cant wait for this thing to start screaming.